Correspondence on "Update on the diagnosis and management of systemic lupus erythematosus"

This review1 provided a comprehensive update on recent developments in systemic lupus erythematosus (SLE) and proposed several new viewpoints. In terms of diagnosis, the authors were the first to put forward two types of clinical SLE, in addition to classified SLE. Particularly, in the European League Against Rheumatism (EULAR)/American College of Rheumatology score <10 category in figure 4, the authors suggested that an immunological score of ≥2 together with a clinical score of ≥6 could be regarded as clinical SLE. Therefore, a patient with any joint involvement (six points) and positive antiphospholipid antibodies (two points) could be considered as having clinical SLE. However, in clinical practice, this patient could also be diagnosed with antiphospholipid syndrome. In addition, in the negative antinuclear antibody category, a patient with positive antiphospholipid antibodies and with joint (six points) and haematologic (four points) involvement could be diagnosed with clinical SLE under their...
Source: Annals of the Rheumatic Diseases - Category: Rheumatology Authors: Tags: ARD Correspondence Source Type: research